|
| Interactions: | AcenocoumarolAdverse Effect: Increased risk of bleeding
Clinical Management: In patients receiving glucagon in doses of 25 mg or more daily for more than two days and Acenocoumarol , the dose of the anticoagulant may need to be reduced and the prothrombin time should be monitored.
Phenindione Adverse Effect: Increased risk of bleeding
Clinical Management: In patients receiving glucagon in doses of 25 mg or more daily for more than two days and Phenindione , the dose of the anticoagulant may need to be reduced and the prothrombin time should be monitored.
Warfarin Adverse Effect: Increased risk of bleeding
Clinical Management: In patients receiving Glucomannan in doses of 25 mg or more daily for more than two days and Warfarin , the dose of Warfarin may need to be reduced and the prothrombin time should be monitored. |
|
|